How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Fast PCR Detection Technologies Market
- By Technology Type: Real-Time PCR (qPCR), Digital PCR (dPCR), Microfluidic PCR, Isothermal PCR, Multiplex PCR
- By End-User: Clinical Diagnostics Laboratories, Research Laboratories, Pharmaceutical and Biotechnology Companies, Point-of-Care Testing Centers, Food Safety Testing Laboratories
- By Application: Infectious Disease Detection, Genetic Disorder Screening, Oncology and Cancer Research, Agricultural and Plant Pathogen Detection, Environmental Monitoring
- By Product Type: PCR Instruments and Systems, PCR Reagents and Kits, PCR Consumables, Software and Services
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Real-Time PCR (qPCR) leads By Technology Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Fast PCR Detection Technologies Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Technology Type 5
End-User 5
Application 5
Product Type 4
Companies profiled
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Roche Diagnostics
Abbott Laboratories
Cepheid (a Danaher company)
Hologic
Agilent Technologies
PerkinElmer
BD (Becton
Dickinson and Company)
Luminex Corporation
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Qiagen
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Roche Diagnostics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Cepheid (a Danaher company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hologic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Agilent Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →PerkinElmer
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BD (Becton
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Dickinson and Company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Luminex Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Mesa Biotech
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →GenMark Diagnostics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Mobidiag
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →QIAGEN N.V.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,038M by 2033 · 10.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Real-Time PCR (qPCR)45.3
- Digital PCR (dPCR)10.8
- Microfluidic PCR11.6
- Isothermal PCR15.2
- Multiplex PCR17.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,346M → $3,315M · 11.9%
Europe$938.1M → $2,180M · 11.1%
Asia Pacific$856.5M → $1,983M · 11.1%
Latin America$530.2M → $1,196M · 10.7%
Middle East and Africa$407.9M → $830.2M · 9.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.402026
10.422027
10.432028
10.452029
10.452030
10.472031
10.492032
10.492033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific23.7
- Bio-Rad Laboratories10.3
- Qiagen11.3
- Roche Diagnostics10.8
- Abbott Laboratories7.4
- Cepheid (a Danaher company)8.6
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology Type14.5%
End-User24.3%
Application27.4%
Product Type33.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.9
- Europe22.9
- Asia Pacific20.9
- Latin America12.6
- Middle East and Africa8.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 85 | 98 | 93 | 80 | 90 | 75 | 87 |
| Bio-Rad Laboratories | 87 | 89 | 85 | 91 | 73 | 76 | 84 |
| Qiagen | 72 | 69 | 83 | 84 | 85 | 64 | 76 |
| Roche Diagnostics | 61 | 73 | 60 | 61 | 72 | 60 | 65 |
| Abbott Laboratories | 75 | 58 | 63 | 73 | 73 | 57 | 67 |
| Cepheid (a Danaher company) | 53 | 67 | 54 | 65 | 61 | 49 | 58 |
| Hologic | 57 | 62 | 62 | 47 | 47 | 56 | 55 |
| Agilent Technologies | 42 | 45 | 56 | 41 | 49 | 48 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Qiagen
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Bio-Rad Laboratories | ✓ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Qiagen | ◐ | − | ◐ | ◐ | ✓ | ✓ |
| Roche Diagnostics | ◐ | ✓ | ◐ | − | ◐ | ◐ |
| Abbott Laboratories | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Cepheid (a Danaher company) | ◐ | ◐ | − | ◐ | ◐ | − |
| Hologic | ◐ | − | − | − | ◐ | ◐ |
| Agilent Technologies | − | − | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific87
2Bio-Rad Laboratories84
3Qiagen76
4Abbott Laboratories67
5Roche Diagnostics65
6Cepheid (a Danaher company)58
7Hologic55
8Agilent Technologies47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificBio-Rad Laboratories
Challenger2
Strong scale, closing on the leaders.
QiagenAbbott Laboratories
Contender2
Focused players with pockets of strength.
Roche DiagnosticsCepheid (a Danaher company)
Niche2
Specialists in a single segment or region.
HologicAgilent Technologies
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology Type in North America, then scale across Fast PCR Detection Technologies Market — a $562M beachhead inside a $9.10B market.
Beachhead (SOM)$562Mobtainable near-term
Serviceable (SAM)$3.34Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Real-Time PCR (qPCR)
Best fit — highest urgency & budget in Technology Type.
Economic buyer78 fit
Digital PCR (dPCR)
Strong fit — clear ROI and a fast path to value.
End user69 fit
Microfluidic PCR
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve22%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Technology Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Fast PCR Detection Technologies Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified22%
Evaluation12%
Closed-won8%
$9.5KCAC
$47KLTV
5.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Fast PCR Detection Technologies Market is a durable-growth opportunity — $4.12B by 2033, compounding at 6.3%.
TAM · 2025$2.52Btoday
TAM · 2033$4.12Bforecast
CAGR6.3%2027–2033
Cumulative$29.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.12BTotal addressable market
SAM$1.68BServiceable available market
SOM$313MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.3% CAGR
Demand compounds through 2033, outpacing GDP across Technology Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.12BLarge & growingTAM by 2033 at 6.3% CAGR
$1.68BServiceable nowreachable with today’s model
$313MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.21BBear4.1% CAGR
$4.12BBase6.3% CAGR
$5.27BBull8.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Fast PCR Detection Technologies Market — a $6.66B market by 2033. Plan: grow share from 9.1% to 18.2%.
Market size · 2033$6.66Btotal addressable
Market CAGR10.5%2027–2033
Target share18.2%from 9.1% today
Revenue ambition$1.21Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.1% | 18.2% | On track |
| Revenue | $580M | $1.21B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 35.6% | 43.3% | On track |
| Customer retention | 87.9% | 93.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-User capability
A defensible second engine — invest in End-User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $154M capacity & capability investment
- Greenlight bolt-on M&A in End-User
- Authorise North America expansion plan
- Fund R&D program for Technology Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Fast PCR Detection Technologies Market conversation — a $9.22B market you can size, segment and defend in minutes.
Market size · 2033$9.22Btotal opportunity
Growth9.1%CAGR to 2033
Addressable buyers1,045+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology Type
Goal Grow share in Technology Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 4 mopayback period
$93K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Thermo Fisher ScientificBio-Rad LaboratoriesQiagenRoche DiagnosticsAbbott LaboratoriesCepheid (a Danaher company)HologicAgilent Technologies+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Fast PCR Detection Technologies Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Fast PCR Detection Technologies Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Fast Melt Tablet Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportFast Dissolving Oral Thin Films (OTFs) Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportFast Dissolving Film Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportFast Biological Reader Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportFast-Acting Insulin Analog Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportFasciola Gigantica ELISA Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportFascia Removal Machine Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportFascia Massager Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportFascial Stapler Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportFascial Gun Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportFascial Closure System Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportFar-UVC Light Source Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.